Inventor · disambiguated record
Gary D. Glick
Also filed as: GLICK GARY · GLICK GARY D
66 granted patents·49 pending applications·636 citations·filing 1997–2024
99Inventor score
Top patents by PatentIndex Score
115 records- 0199US10980756B1Methods of treatmentFIRST WAVE BIO INC·Filed 2020·Granted Apr 20, 2021·34 cites·26 claims
- 0297US10744103B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Granted Aug 18, 2020·7 cites·29 claims
- 0397US7144880B2Compositions relating to novel compounds and targets thereofUNIV MICHIGAN·Filed 2003·Granted Dec 5, 2006·49 cites·10 claims
- 0496US11564896B2Methods of treatmentFIRST WAVE BIO INC·Filed 2021·Granted Jan 31, 2023·2 cites·16 claims
- 0596US10772854B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2018·Granted Sep 15, 2020·6 cites·72 claims
- 0696US7851465B2Compositions and methods relating to novel compounds and targets thereofUNIV MICHIGAN·Filed 2008·Granted Dec 14, 2010·32 cites·27 claims
- 0796US7683046B2Benzodiazepine compositions for treating epidermal hyperplasia and related disordersUNIV MICHIGAN·Filed 2008·Granted Mar 23, 2010·31 cites·12 claims
- 0896US7276348B2Compositions and methods relating to F1F0-ATPase inhibitors and targets thereofUNIV MICHIGAN·Filed 2004·Granted Oct 2, 2007·54 cites·8 claims
- 0995US10912746B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Feb 9, 2021·3 cites·20 claims
- 1095US10905666B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Feb 2, 2021·3 cites·26 claims
- 1195US10849867B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2020·Granted Dec 1, 2020·3 cites·28 claims
- 1295US10799468B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Granted Oct 13, 2020·3 cites·28 claims
- 1395US7638624B2Compositions and methods relating to novel benzodiazepine compounds and derivativesUNIV MICHIGAN·Filed 2006·Granted Dec 29, 2009·35 cites·19 claims
- 1495US7125866B1Therapeutic applications of pro-apoptotic benzodiazepinesUNIV MICHIGAN·Filed 2000·Granted Oct 24, 2006·63 cites·4 claims
- 1594US10292951B2Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2016·Granted May 21, 2019·9 cites·60 claims
- 1693US10604542B2Cyclic dinucleotides for treating conditions associated with sting activity such as cancerINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Mar 31, 2020·5 cites·30 claims
- 1793US10556903B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2017·Granted Feb 11, 2020·12 cites·5 claims
- 1892US10533005B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted Jan 14, 2020·9 cites·41 claims
- 1991US7572788B2Compositions and methods relating to novel compounds and targets thereofUNIV MICHIGAN·Filed 2003·Granted Aug 11, 2009·35 cites·19 claims
- 2091US7220739B2Therapeutic application of pro-apoptotic benzodiazepinesUNIV MICHIGAN·Filed 2001·Granted May 22, 2007·35 cites·3 claims
- 2190US11724992B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 2290US9512111B2N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseGLICK GARY D·Filed 2011·Granted Dec 6, 2016·21 cites·15 claims
- 2389US10961270B2Compounds and compositions for treating conditions associated with sting activityINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Mar 30, 2021·2 cites·7 claims
- 2488US9370507B2Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2015·Granted Jun 21, 2016·8 cites·27 claims
- 2588US9000014B2Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofGLICK GARY D·Filed 2011·Granted Apr 7, 2015·12 cites·26 claims
- 2688US8497307B2Aryl guanidine F1F0-ATPase inhibitors and related methodsGLICK GARY D·Filed 2009·Granted Jul 30, 2013·20 cites·26 claims
- 2788US8324258B2F1F0-ATPase inhibitors and related methodsGLICK GARY D·Filed 2008·Granted Dec 4, 2012·20 cites·15 claims
- 2888US6080588ATherapeutic methods for benzodiazepine derivativesUNIV MICHIGAN·Filed 1997·Granted Jun 27, 2000·81 cites·3 claims
- 2987US10533007B2NLRP3 modulatorsInnate Tumor Immunity·Filed 2017·Granted Jan 14, 2020·10 cites·2 claims
- 3087US9139532B2Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereofGLICK GARY D·Filed 2011·Granted Sep 22, 2015·8 cites·32 claims
- 3187US2024074995A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2023·Application pending·0 cites
- 3285US12351580B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2023·Granted Jul 8, 2025·0 cites·6 claims
- 3385US9580388B2Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2015·Granted Feb 28, 2017·4 cites·27 claims
- 3485US8722667B2Compositions and methods for inhibiting the proliferation of cellsUNIV MICHIGAN·Filed 2012·Granted May 13, 2014·2 cites·12 claims
- 3584US12084424B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2023·Granted Sep 10, 2024·0 cites·3 claims
- 3684US11370763B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Jun 28, 2022·1 cites·13 claims
- 3784US10654816B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS INFLAMMASOME RES INC·Filed 2019·Granted May 19, 2020·3 cites·19 claims
- 3881US11203579B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Dec 21, 2021·2 cites·19 claims
- 3980US2023201143A1Methods of treatmentFIRST WAVE BIO INC·Filed 2022·Application pending·0 cites
- 4079US8242109B2Compositions and methods relating to novel compounds and targets thereofGLICK GARY D·Filed 2010·Granted Aug 14, 2012·3 cites·15 claims
- 4178US11793777B2Methods and compositions for treating conditions associated with an abnormal inflammatory responseFIRST WAVE BIO INC·Filed 2021·Granted Oct 24, 2023·0 cites·18 claims
- 4278US11072612B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2019·Granted Jul 27, 2021·1 cites·5 claims
- 4377US2024391884A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2024·Application pending·0 cites
- 4477US2022000812A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2021·Application pending·0 cites
- 4576US11744812B2Methods of treatmentFIRST WAVE BIO INC·Filed 2021·Granted Sep 5, 2023·0 cites·27 claims
- 4676US8604023B21,4-benzodiazepinone compounds and their use in treating cancerGLICK GARY D·Filed 2010·Granted Dec 10, 2013·2 cites·24 claims
- 4775US9932313B2Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2017·Granted Apr 3, 2018·1 cites·25 claims
- 4875US8088759B21,4-benzodiazepine-2,5-diones with therapeutic propertiesGLICK GARY D·Filed 2006·Granted Jan 3, 2012·1 cites·14 claims
- 4975US2020276140A1Methods and compositions for treating conditions associated with an abnormal inflammatory responsesFIRST WAVE BIO INC·Filed 2020·Application pending·0 cites
- 5074US11760735B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2022·Granted Sep 19, 2023·0 cites·9 claims
Showing the top 50 of 115 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gary D. Glick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →